Who owns ESTRELLA IMMUNOPHARMA INC?
- Ticker: ESLA
- CUSIP Number: 297584104
Tip: Access positions for across all investors
Analyze quarterly positions in Estrella Immunopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Estrella Immunopharma stock
Who bought or sold ESTRELLA IMMUNOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 449k | $700k | 7% | Dec 2025 |
|
| Renaissance Technologies | 123k | $191k | 1046% | Dec 2025 |
|
| Geode Capital Management | 110k | $171k | 8% | Dec 2025 |
|
| Marshall Wace | 56k | $88k | 100% | Dec 2025 |
|
| Citadel Advisors | 50k | $60k | 0% | Sep 2025 |
|
| XTX Topco | 50k | $77k | 377% | Dec 2025 |
|
| State Street Corporation | 43k | $68k | 94% | Dec 2025 |
|
| Atw Spac Management | 40k | $46k | 0% | Sep 2025 |
|
| Quadrature Capital | 28k | $43k | 100% | Dec 2025 |
|
| BlackRock | 27k | $41k | 10% | Dec 2025 |
|
| Northern Trust | 20k | $31k | 100% | Dec 2025 |
|
| Jane Street | 10k | $16k | 100% | Dec 2025 |
|
| Maso Capital Partners | 10k | $12k | 0% | Sep 2025 |
|
| UBS Group | 3.2k | $5.0k | -94% | Dec 2025 |
|
Who sold out of Estrella Immunopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tower Research Capital | Sep 2025 | 4.0k | $4.6k |